+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Troponin Tests - Medical Devices Pipeline Assessment, 2020

  • ID: 5230937
  • Report
  • November 2020
  • Region: Global
  • 54 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • Abbott Diagnostics
  • Bioscience Inc
  • Coulter Inc
  • Diagnostics Inc
  • Diagnostics LTD
  • Healthineers AG
  • MORE
Summary

The publisher's Medical Devices sector report, “Troponin Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Troponin Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Troponin Tests diagnostic tests enables to measure troponin levels specific to cardiovascular diseases in patient’s sample.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Troponin Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Troponin Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Troponin Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott Diagnostics
  • Bioscience Inc
  • Coulter Inc
  • Diagnostics Inc
  • Diagnostics LTD
  • Healthineers AG
  • MORE
1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Troponin Tests Overview

3 Products under Development
3.1 Troponin Tests - Pipeline Products by Stage of Development
3.2 Troponin Tests - Pipeline Products by Territory
3.3 Troponin Tests - Pipeline Products by Regulatory Path
3.4 Troponin Tests - Pipeline Products by Estimated Approval Date
3.5 Troponin Tests - Ongoing Clinical Trials

4 Troponin Tests - Pipeline Products under Development by Companies
4.1 Troponin Tests Companies - Pipeline Products by Stage of Development
4.2 Troponin Tests - Pipeline Products by Stage of Development

5 Troponin Tests Companies and Product Overview
5.1 Abbott Diagnostics Company Overview
5.2 AgPlus Diagnostics LTD Company Overview
5.3 AXO Science SAS Company Overview
5.4 Beckman Coulter Inc Company Overview
5.5 British Heart Foundation Company Overview
5.6 China Medical Technologies Inc (Inactive) Company Overview
5.7 Johns Hopkins University Company Overview
5.8 Nanosphere Inc Company Overview
5.9 Ortho-Clinical Diagnostics Inc Company Overview
5.10 Roche Diagnostics International Ltd Company Overview
5.11 SDIX LLC Company Overview
5.12 Siemens Healthcare Diagnostics Inc Company Overview
5.13 Siemens Healthineers AG Company Overview
5.14 Singulex Inc Company Overview
5.15 Soroka University Medical Center Company Overview
5.16 Tosoh Bioscience Inc Company Overview
5.17 University of Alberta Company Overview
5.18 Upstream Medical Technologies Ltd Company Overview

6 Troponin Tests- Recent Developments
6.1 Jun 09, 2020: Siemens and Exyte join forces to deliver integrated solutions for fast-track construction of smart biotech facilities
6.2 Feb 03, 2020: Siemens Healthineers starts new fiscal year with strong growth – outlook confirmed
6.3 Dec 10, 2019: Siemens Healthineers gives details on second phase of Strategy 2025 and on the further development of its businesses

7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Troponin Tests - Pipeline Products by Stage of Development
Table 2: Troponin Tests - Pipeline Products by Territory
Table 3: Troponin Tests - Pipeline Products by Regulatory Path
Table 4: Troponin Tests - Pipeline Products by Estimated Approval Date
Table 5: Troponin Tests - Ongoing Clinical Trials
Table 6: Troponin Tests Companies - Pipeline Products by Stage of Development
Table 7: Troponin Tests - Pipeline Products by Stage of Development
Table 8: Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
Table 9: ARCHITECT c4000 System - High Sensitive Troponin-I Assay - Product Status
Table 10: ARCHITECT c4000 System - High Sensitive Troponin-I Assay - Product Description
Table 11: ARCHITECT c8000 System - High Sensitive Troponin-I Assay - Product Status
Table 12: ARCHITECT c8000 System - High Sensitive Troponin-I Assay - Product Description
Table 13: Abbott Diagnostics - Ongoing Clinical Trials Overview
Table 14: ARCHITECT c4000 System - High Sensitive Troponin-I Assay - The Study of High-sensitivity Cardiac Troponin I Values and Changes in Diagnosis of Suspected Acute Coronary Syndrome Patients in China
Table 15: ARCHITECT c8000 System - High Sensitive Troponin-I Assay - Australian New Zealand Acute Chest Pain (ANZACP) Registry: A Registry of the Investigation, Management and Outcomes of Patients Presenting to Two Australasian Hospitals with Chest Pain of Possible Cardiac Origin
Table 16: ARCHITECT c8000 System - High Sensitive Troponin-I Assay - The Study of High-sensitivity Cardiac Troponin I Values and Changes in Diagnosis of Suspected Acute Coronary Syndrome Patients in China
Table 17: AgPlus Diagnostics LTD Pipeline Products & Ongoing Clinical Trials Overview
Table 18: AgPlus Diagnostic System - Troponin I Assay - Product Status
Table 19: AgPlus Diagnostic System - Troponin I Assay - Product Description
Table 20: AXO Science SAS Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Multiplexed Detection - Troponin - Product Status
Table 22: Multiplexed Detection - Troponin - Product Description
Table 23: Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 24: UniCel DxI 600 Access Immunoassay System - hsTnI Assay - Product Status
Table 25: UniCel DxI 600 Access Immunoassay System - hsTnI Assay - Product Description
Table 26: UniCel DxI 800 Access Immunoassay System - hsTnI Assay - Product Status
Table 27: UniCel DxI 800 Access Immunoassay System - hsTnI Assay - Product Description
Table 28: British Heart Foundation Pipeline Products & Ongoing Clinical Trials Overview
Table 29: Diagnostic Blood Test - Heart Attack - Product Status
Table 30: Diagnostic Blood Test - Heart Attack - Product Description
Table 31: China Medical Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 32: Diagnostic Assay - Cardiac Troponin I - Product Status
Table 33: Diagnostic Assay - Cardiac Troponin I - Product Description
Table 34: Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
Table 35: Cardiac Troponin I Assay - Product Status
Table 36: Cardiac Troponin I Assay - Product Description
Table 37: Nanosphere Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 38: Ultra-Sensitive Protein Assay - Cardiac Troponin I - Product Status
Table 39: Ultra-Sensitive Protein Assay - Cardiac Troponin I - Product Description
Table 40: Ultra-Sensitive Protein Assay - Chronic Heart Failure - Product Status
Table 41: Ultra-Sensitive Protein Assay - Chronic Heart Failure - Product Description
Table 42: Ortho-Clinical Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 43: Enhanced Chemiluminescent High Sensitivity Troponin I Assay - Product Status
Table 44: Enhanced Chemiluminescent High Sensitivity Troponin I Assay - Product Description
Table 45: VITROS 5600 Integrated System - High Sensitivity Troponin Assay - Product Status
Table 46: VITROS 5600 Integrated System - High Sensitivity Troponin Assay - Product Description
Table 47: VITROS XT 7600 Integrated System - High Sensitivity Troponin I Assay - Product Status
Table 48: VITROS XT 7600 Integrated System - High Sensitivity Troponin I Assay - Product Description
Table 49: Ortho-Clinical Diagnostics Inc - Ongoing Clinical Trials Overview

List of Figures
Figure 1: Troponin Tests - Pipeline Products by Stage of Development
Figure 2: Troponin Tests - Pipeline Products by Territory
Figure 3: Troponin Tests - Pipeline Products by Regulatory Path
Figure 4: Troponin Tests - Pipeline Products by Estimated Approval Date
Figure 5: Troponin Tests - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 3
  • Abbott Diagnostics
  • Diagnostics LTD
  • Science SAS
  • Coulter Inc
  • Heart Foundation
  • Medical Technologies Inc (Inactive)
  • Hopkins University
  • Diagnostics Inc
  • Diagnostics International Ltd
  • Healthcare Diagnostics Inc
  • Healthineers AG
  • University Medical Center
  • Bioscience Inc
Note: Product cover images may vary from those shown
Adroll
adroll